30.05.2007 genOway has been selected by the German National Genome Research Network to focus on human diseases: NGFN to fund genOway with 1.1 million euro

 29.05.2007 Amgen Oncology Highlights Upcoming Data Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting

 29.05.2007 Oxford Biomedica and Collaborators to Present TroVax^® Phase Il Trial Results in Renal Cancer at American Society of Clinical Oncology Meeting’

  25.05.2007 Amgen to Appeal CHMP Opinion on Vectibix(TM) (Panitumumab)

  24.05.2007 Amgen Prices $4 Billion of Senior Notes in Three Series; Company to Purchase Approximately $3 Billion in Common Stock

  17.05.2007 Oxford Biomedica Announces that Phase II Results with HI-8^® MEL in Melanoma will be Presented at American Association of Immunologists Meeting

  16.05.2007 Pharmion Corporation to Present at Citigroup 2007 Healthcare Conference

  16.05.2007 MorphoSys AG Shareholder Assembly Approves Three-for-One Stock Split - Dr. Walter Blättler appointed new Supervisory Board member

08.05.2007 Oxford Biomedica collaborators in transgenics achieve expression breakthrought using OVA™ system for therapeutics protein production

  04.05.2007 Active Biotech Interim Report Jan-March 2007

  04.05.2007 Amarin Announces First Quarter 2007 Results Conference Call

  04.05.2007 MediGene  Presents Report on the First Quarter of 2007

01.05.2007 LAQUINIMOD, a novel oral compound, showed significant reduction in disease activity in Patients with relapsing-remitting multiple sclerosis (RRMS)